Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-06

Clinical Trial Update: Norovirus Challenge Study [Phase 1, Phase 2]

View source ↗

Summary

Vaxart completed a Phase 1/2 Norovirus challenge study and posted results in May 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaxart Norovirus vaccine (candidate)

Snippet

Sponsor: Vaxart | Conditions: Norovirus Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-06